Back
Neurocrine Biosciences, Inc. Stock Price Chart
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
68
NBIX
Neurocrine Biosciences, Inc.
Last Price:
$148.69
Seasonality Move:
9.22%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is moderately bearish and NBIX is experiencing slight buying pressure.
Neurocrine Biosciences, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 154.62 | Sell |
| 20-day SMA: | 149.09 | Buy |
| 50-day SMA: | 145.41 | Buy |
| 200-day SMA: | 129.07 | Buy |
| 8-day EMA: | 153.65 | Buy |
| 20-day EMA: | 150.95 | Buy |
| 50-day EMA: | 146.65 | Buy |
| 200-day EMA: | 135.76 | Buy |
Neurocrine Biosciences, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.86 | Buy |
| Relative Strength Index (14 RSI): | 59.94 | Buy |
| Chaikin Money Flow: | 251442 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (142.79 - 154.41) | Buy |
| Bollinger Bands (100): | (133.53 - 148.71) | Buy |
Neurocrine Biosciences, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurocrine Biosciences, Inc. Stock
Is Neurocrine Biosciences, Inc. Stock a Buy?
-
Neurocrine Biosciences, Inc. share price is 154.06 while NBIX 8-day simple moving average is 154.62, which is a Sell signal.
-
The stock price of NBIX is 154.06 while Neurocrine Biosciences, Inc. 20-day SMA is 149.09, which makes it a Buy.
-
Neurocrine Biosciences, Inc. 50-day simple moving average is 145.41 while NBIX share price is 154.06, making it a Buy technically.
-
NBIX stock price is 154.06 and Neurocrine Biosciences, Inc. 200-day simple moving average is 129.07, creating a Buy signal.
NBIX Technical Analysis vs Fundamental Analysis
Buy
68
Neurocrine Biosciences, Inc. (NBIX)
is a Buy
Is Neurocrine Biosciences, Inc. a Buy or a Sell?
-
Neurocrine Biosciences, Inc. stock is rated a BuyThe current Neurocrine Biosciences, Inc. [NBIX] share price is $154.06. The Score for NBIX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
Neurocrine Biosciences, Inc. Stock Info
Market Cap:
15.4B
Price in USD:
154.06
Share Volume:
768.2K
Neurocrine Biosciences, Inc. 52-Week Range
52-Week High:
160.18
52-Week Low:
84.23
Buy
68
Neurocrine Biosciences, Inc. (NBIX)
is a Buy
Neurocrine Biosciences, Inc. Share Price Forecast
-
What is the Neurocrine Biosciences, Inc. stock price today?The Neurocrine Biosciences, Inc. stock price is 154.06 USD today.
-
Will NBIX stock go up or go down?Neurocrine Biosciences, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Neurocrine Biosciences, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurocrine Biosciences, Inc. is not overvalued.
Is Neurocrine Biosciences, Inc. Stock a Buy?
-
Neurocrine Biosciences, Inc. share price is 154.06 while NBIX 8-day exponential moving average is 153.65, which is a Buy signal.
-
The stock price of NBIX is 154.06 while Neurocrine Biosciences, Inc. 20-day EMA is 150.95, which makes it a Buy.
-
Neurocrine Biosciences, Inc. 50-day exponential moving average is 146.65 while NBIX share price is 154.06, making it a Buy technically.
-
NBIX stock price is 154.06 and Neurocrine Biosciences, Inc. 200-day simple moving average is 135.76, creating a Buy signal.
Fundamental Analysis of Neurocrine Biosciences, Inc.
Is Neurocrine Biosciences, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $2.24 per share.
Technical Analysis of Neurocrine Biosciences, Inc.
Should I short Neurocrine Biosciences, Inc. stock?
-
NBIX Moving Average Covergence Divergence (MACD) indicator is 2.86, suggesting Neurocrine Biosciences, Inc. is a Buy
-
Neurocrine Biosciences, Inc. Relative Strength Index (RSI) is 59.94, which suggest Neurocrine Biosciences, Inc. is overbought
-
The Bollinger Bands (25) for Neurocrine Biosciences, Inc. is (142.79 - 154.41), which suggest Neurocrine Biosciences, Inc. is a Buy
-
The Bollinger Bands (100) for Neurocrine Biosciences, Inc. is (133.53 - 148.71), which suggest Neurocrine Biosciences, Inc. is a Buy
* Neurocrine Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.